For example, Nieman et al. observed highly expressed FABP4 in omental metastases but not in primary ovarian cancers [18]; Uehara et al. also reported that FABP4 could promote human prostate cancer cell progression by binding to FAs [59]. This evidence concerns the gene FABP4 and ovarian cancer.